NextTrip, Inc. — Director's Dealing 2018

Apr 24, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SIGMA LABS, INC. (SGLB)
CIK: 0000788611
Period of Report: 2018-04-19

Reporting Person: Rice John Reynolds (Director, Interim CEO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-04-19	Stock Option (right to buy)	$1.88	A	20000	Acquired	2023-04-18	Common Stock (20000)	Direct
2018-04-19	Stock Option (right to buy)	$1.54	A	20000	Acquired	2023-04-18	Common Stock (20000)	Direct
2018-04-19	Stock Option (right to buy)	$1.48	A	20000	Acquired	2023-04-18	Common Stock (20000)	Direct

Footnotes

F1: The stock option is vested as to 1,000 shares, and the balance of the shares under the stock option will vest in four annual installments over four years from the date of grant (the "Grant Date"), as follows: 950 shares will vest and become exercisable on the one-year anniversary of the Grant Date; 2,850 shares will vest and become exercisable on the second-year anniversary of the Grant Date; 4,750 shares will vest and become exercisable on the third-year anniversary of the Grant Date; and 10,450 shares will vest and become exercisable on the four-year anniversary of the Grant Date.